Dr Richard M Wolkowitz, MD | |
305 N Keene St, Suite 105, Columbia, MO 65201-6897 | |
(573) 442-2299 | |
(573) 442-1409 |
Full Name | Dr Richard M Wolkowitz |
---|---|
Gender | Male |
Speciality | Pain Management |
Experience | 33 Years |
Location | 305 N Keene St, Columbia, Missouri |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1477547461 | NPI | - | NPPES |
208000224 | Medicaid | MO |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207LP2900X | Anesthesiology - Pain Medicine | 108975 (Missouri) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Heart Of The Rockies Regional Medical Center | Salida, CO | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Salida Hospital District | 3577451152 | 82 |
News Archive
The coauthors of The Independent Budget (IB)—AMVETS, Disabled American Veterans, Paralyzed Veterans of America and Veterans of Foreign Wars who collectively represent millions of veterans—are applauding the Administration's recently released Budget Request for FY 2011. The budget request includes significant funding increases for Department of Veterans Affairs (VA) health care and benefits, and for the first time, advance appropriation recommendations for the VA FY 2012 budget.
Researchers of the laboratory "Medical ultrasound equipment" of Peter the Great St. Petersburg Polytechnic University developed a high-tech device-transformer for ultrasound examination, named "Ultrasound mobile". The new equipment is the combination of three modifications in one device.
Cytokine PharmaSciences, Inc. today announced the completion of a Phase II study of the misoprostol vaginal insert (MVI), a proprietary, controlled-release and retrievable polymer chip containing prostaglandin E(1) (PGE1). Results of the dose-finding study in pregnant women at term gestation confirm the efficacy and safety of this investigational product and suggest that the MVI may reduce time to delivery after induction, support more natural labor, and reduce the rate of cesarean delivery.
A collaborative research effort by scientists at the University of North Carolina School of Medicine, Duke University, and University College of London in the UK, sheds new light on alcohol-related birth defects.
Virginia Tech scientists have developed a new cancer drug that uses gold nanoparticles created by the biotech firm CytImmune Sciences to deliver paclitaxel — a commonly used chemotherapy drug directly to a tumor.
› Verified 9 days ago
Entity Name | Salida Hospital District |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1972778272 PECOS PAC ID: 3577451152 Enrollment ID: O20040413000292 |
News Archive
The coauthors of The Independent Budget (IB)—AMVETS, Disabled American Veterans, Paralyzed Veterans of America and Veterans of Foreign Wars who collectively represent millions of veterans—are applauding the Administration's recently released Budget Request for FY 2011. The budget request includes significant funding increases for Department of Veterans Affairs (VA) health care and benefits, and for the first time, advance appropriation recommendations for the VA FY 2012 budget.
Researchers of the laboratory "Medical ultrasound equipment" of Peter the Great St. Petersburg Polytechnic University developed a high-tech device-transformer for ultrasound examination, named "Ultrasound mobile". The new equipment is the combination of three modifications in one device.
Cytokine PharmaSciences, Inc. today announced the completion of a Phase II study of the misoprostol vaginal insert (MVI), a proprietary, controlled-release and retrievable polymer chip containing prostaglandin E(1) (PGE1). Results of the dose-finding study in pregnant women at term gestation confirm the efficacy and safety of this investigational product and suggest that the MVI may reduce time to delivery after induction, support more natural labor, and reduce the rate of cesarean delivery.
A collaborative research effort by scientists at the University of North Carolina School of Medicine, Duke University, and University College of London in the UK, sheds new light on alcohol-related birth defects.
Virginia Tech scientists have developed a new cancer drug that uses gold nanoparticles created by the biotech firm CytImmune Sciences to deliver paclitaxel — a commonly used chemotherapy drug directly to a tumor.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Richard M Wolkowitz, MD 1000 Rush Dr, Salida, CO 81201-9627 Ph: (719) 530-2000 | Dr Richard M Wolkowitz, MD 305 N Keene St, Suite 105, Columbia, MO 65201-6897 Ph: (573) 442-2299 |
News Archive
The coauthors of The Independent Budget (IB)—AMVETS, Disabled American Veterans, Paralyzed Veterans of America and Veterans of Foreign Wars who collectively represent millions of veterans—are applauding the Administration's recently released Budget Request for FY 2011. The budget request includes significant funding increases for Department of Veterans Affairs (VA) health care and benefits, and for the first time, advance appropriation recommendations for the VA FY 2012 budget.
Researchers of the laboratory "Medical ultrasound equipment" of Peter the Great St. Petersburg Polytechnic University developed a high-tech device-transformer for ultrasound examination, named "Ultrasound mobile". The new equipment is the combination of three modifications in one device.
Cytokine PharmaSciences, Inc. today announced the completion of a Phase II study of the misoprostol vaginal insert (MVI), a proprietary, controlled-release and retrievable polymer chip containing prostaglandin E(1) (PGE1). Results of the dose-finding study in pregnant women at term gestation confirm the efficacy and safety of this investigational product and suggest that the MVI may reduce time to delivery after induction, support more natural labor, and reduce the rate of cesarean delivery.
A collaborative research effort by scientists at the University of North Carolina School of Medicine, Duke University, and University College of London in the UK, sheds new light on alcohol-related birth defects.
Virginia Tech scientists have developed a new cancer drug that uses gold nanoparticles created by the biotech firm CytImmune Sciences to deliver paclitaxel — a commonly used chemotherapy drug directly to a tumor.
› Verified 9 days ago
Sarah Marie Von Thaer, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: One Hospital Dr, Columbia, MO 65212 Phone: 573-882-2568 Fax: 855-903-0985 | |
Ryan Daniel Montgomery, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Hospital Dr, Columbia, MO 65212 Phone: 573-882-2568 Fax: 855-903-0985 | |
Thomas Wesley Meyer, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1600 E Broadway, Columbia, MO 65201 Phone: 573-815-6262 Fax: 573-815-2308 | |
Dr. Oleksiy Mykhaylovych Zyernov, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Hospital Dr, Dc056.20, Columbia, MO 65212 Phone: 573-882-2568 Fax: 885-903-0985 | |
Frederick T O'donnell, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Hospital Dr, Columbia, MO 65201 Phone: 573-882-2568 Fax: 573-882-2226 | |
Stephanie Elizabeth Cain, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 1 Hospital Dr, Columbia, MO 65212 Phone: 573-884-3466 | |
Eric Kenneth Jagim, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1 Hospital Dr, Columbia, MO 65212 Phone: 573-882-2568 Fax: 573-882-2226 |